What is Bevacizumab: Uses, Dosage, Side Effects and More

Bevacizumab is a targeted cancer medication that helps slow tumor growth by blocking blood vessel formation. This specialized treatment works by cutting off the blood supply that tumors need to grow and spread throughout your body.

As a monoclonal antibody, bevacizumab represents a more precise approach to cancer treatment compared to traditional chemotherapy. Your oncologist might recommend this medication as part of your comprehensive cancer care plan, often alongside other treatments to give you the best possible outcome.

What is Bevacizumab?

Bevacizumab is a laboratory-made protein that mimics your body's natural immune system antibodies. It specifically targets a protein called VEGF (vascular endothelial growth factor) that tumors use to create new blood vessels.

Think of VEGF as a signal that tells your body to build highways for blood flow. Cancer cells send out lots of these signals to get the nutrients they need to grow. Bevacizumab blocks these signals, essentially cutting off the tumor's food supply.

This medication belongs to a class called angiogenesis inhibitors, which means it prevents the formation of new blood vessels. By doing this, it can help slow down cancer growth and make other cancer treatments work more effectively.

What is Bevacizumab Used For?

Bevacizumab treats several types of advanced cancers, particularly when they have spread or returned after initial treatment. Your doctor prescribes it when cancer cells have developed their own blood supply networks.

The most common cancers treated with bevacizumab include colorectal cancer, lung cancer, kidney cancer, and certain brain tumors called glioblastomas. It's also used for some gynecologic cancers like ovarian and cervical cancer.

Your oncologist typically combines bevacizumab with chemotherapy rather than using it alone. This combination approach often works better than either treatment by itself, giving your body multiple ways to fight the cancer.

In some cases, doctors use bevacizumab for eye conditions like wet age-related macular degeneration, though this requires a different formulation and dosing schedule than cancer treatment.

How Does Bevacizumab Work?

Bevacizumab works by binding to VEGF proteins in your bloodstream, preventing them from attaching to receptors on blood vessel cells. This blocks the signal that would normally tell your body to grow new blood vessels toward the tumor.

As a targeted therapy, bevacizumab is considered a moderate-strength medication that works differently from traditional chemotherapy. Instead of directly killing cancer cells, it starves them by cutting off their blood supply.

The medication circulates through your bloodstream for several weeks after each infusion. During this time, it continuously blocks VEGF signals, helping to normalize the chaotic blood vessel networks that tumors create.

This approach can make tumors more vulnerable to other treatments like chemotherapy or radiation, which is why doctors often use bevacizumab as part of combination therapy rather than alone.

How Should I Take Bevacizumab?

Bevacizumab is given only through an intravenous (IV) infusion at a cancer treatment center or hospital. You cannot take this medication by mouth or inject it yourself at home.

Your first infusion typically takes about 90 minutes, allowing your medical team to monitor how your body responds. If you tolerate it well, subsequent infusions may be shortened to 60 minutes, and eventually to 30 minutes.

You don't need to fast before treatment, but eating a light meal beforehand can help you feel more comfortable during the infusion. Bring water and snacks, as you'll be sitting for an extended period.

Your infusion nurse will check your vital signs regularly and watch for any immediate reactions. The medication is mixed with saline solution and given slowly through your IV line to minimize side effects.

How Long Should I Take Bevacizumab For?

The duration of bevacizumab treatment varies greatly depending on your specific cancer type, stage, and how well you respond to therapy. Most patients receive infusions every 2-3 weeks for several months.

Your oncologist will monitor your cancer through regular scans and blood tests to determine if the treatment is working. If your cancer is responding well and you're tolerating the medication, treatment may continue for 6-12 months or longer.

Some patients continue bevacizumab as maintenance therapy even after their cancer appears controlled. This ongoing treatment helps prevent the cancer from developing new blood vessels and potentially growing again.

Your doctor will discuss stopping treatment if your cancer progresses despite therapy, if you develop serious side effects, or if you need surgery that requires healing time.

What Are the Side Effects of Bevacizumab?

Understanding potential side effects helps you know what to expect and when to contact your healthcare team. Most people experience some side effects, but they're often manageable with proper support and monitoring.

Common side effects that many patients experience include high blood pressure, fatigue, and nosebleeds. You might also notice changes in your sense of taste, mild nausea, or increased bruising from minor bumps.

Here are the most frequently reported side effects:

• High blood pressure requiring medication adjustments
• Fatigue and weakness that may worsen over time
• Nosebleeds or other minor bleeding episodes
• Protein in your urine detected through regular testing
• Taste changes that affect your appetite
• Mild to moderate nausea
• Increased bruising or slow wound healing

More serious side effects require immediate medical attention, though they occur less frequently. These complications can be life-threatening if not addressed promptly by your healthcare team.

Rare but serious side effects include:

• Severe bleeding in your stomach, lungs, or brain
• Blood clots in your legs, lungs, or heart
• Holes or tears in your intestinal wall (perforation)
• Severe high blood pressure crisis
• Heart problems including heart failure
• Kidney damage with protein loss
• Severe allergic reactions during infusion

Your medical team monitors for these serious complications through regular blood tests, blood pressure checks, and physical exams. Early detection and treatment of side effects can prevent most complications from becoming dangerous.

Who Should Not Take Bevacizumab?

Certain medical conditions and situations make bevacizumab unsafe or require special precautions. Your oncologist will carefully review your medical history before recommending this treatment.

You should not receive bevacizumab if you're currently pregnant or planning to become pregnant, as it can cause serious birth defects. Women of childbearing age must use effective contraception during treatment and for six months afterward.

People with recent major surgery or planned surgical procedures typically cannot receive bevacizumab. The medication impairs wound healing, so you'll need to stop treatment at least 28 days before any planned surgery.

Additional conditions that may prevent bevacizumab use include:

• Uncontrolled high blood pressure despite medication
• Recent history of serious bleeding episodes
• Current blood clotting disorders
• Severe heart disease or recent heart attack
• Active infections that aren't responding to treatment
• Severe kidney disease with protein loss
• Recent stroke or brain bleeding

Your doctor will weigh the potential benefits against these risks for your specific situation. Sometimes modifications to your treatment plan or additional monitoring can make bevacizumab safer for people with certain conditions.

Bevacizumab Brand Names

Bevacizumab is available under several brand names, with Avastin being the most widely recognized original formulation. This brand name version has been used in cancer treatment for many years with extensive research backing its effectiveness.

Biosimilar versions of bevacizumab are now available, offering the same therapeutic benefits at potentially lower costs. These include Mvasi, Zirabev, and Alymsys, all of which have been approved as equivalent to the original Avastin.

Your insurance coverage may influence which brand your doctor prescribes, but all approved versions contain the same active ingredient and work identically in your body. The choice between brands typically depends on availability and cost considerations rather than medical differences.

Bevacizumab Alternatives

Several other medications work similarly to bevacizumab by targeting blood vessel formation, though each has unique characteristics and approved uses. Your oncologist might consider these alternatives based on your specific cancer type and medical history.

Ramucirumab (Cyramza) is another VEGF-targeting medication used primarily for stomach and lung cancers. It works through a slightly different mechanism but achieves similar results in blocking tumor blood vessel growth.

Other angiogenesis inhibitors include aflibercept (Zaltrap) for colorectal cancer and regorafenib (Stivarga) for advanced colorectal and liver cancers. These medications offer oral administration options, which some patients prefer over IV infusions.

For certain cancers, immunotherapy drugs like pembrolizumab (Keytruda) or nivolumab (Opdivo) might be considered instead of or alongside bevacizumab, depending on your cancer's specific characteristics and biomarkers.

Is Bevacizumab Better Than Other Similar Medications?

Bevacizumab was the first approved VEGF inhibitor and has the most extensive research data supporting its use across multiple cancer types. This long track record helps doctors predict how you might respond to treatment.

Compared to newer alternatives like ramucirumab, bevacizumab often has more treatment combinations available and broader approval for different cancer types. However, the "best" choice depends entirely on your specific cancer characteristics and medical situation.

Some studies suggest that certain patients may respond better to alternative VEGF inhibitors, while others do best with bevacizumab. Your oncologist considers factors like your cancer's genetic markers, previous treatments, and overall health when making this decision.

The effectiveness comparison often depends on what other treatments you're receiving alongside the VEGF inhibitor. Bevacizumab's extensive research in combination therapies gives it an advantage in treatment planning for many situations.